Molecular Marker for Predicting Treatment Response in Advanced Renal Cell Carcinoma: Does the Promise Fulfill Clinical Need?
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular Marker for Predicting Treatment Response in Advanced Renal Cell Carcinoma: Does the Promise Fulfill Clinical Need?
Authors
Keywords
Metastatic renal cell carcinoma, Tyrosine kinase inhibitors, Prognostic markers, Sunitinib, Sorafenib
Journal
Current Urology Reports
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-12-16
DOI
10.1007/s11934-013-0375-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The cost-effectiveness of screening lung cancer patients for targeted drug sensitivity markers
- (2012) A J Atherly et al. BRITISH JOURNAL OF CANCER
- Increase in Cholesterol Predicts Survival Advantage in Renal Cell Carcinoma Patients Treated with Temsirolimus
- (2012) C. K. Lee et al. CLINICAL CANCER RESEARCH
- Validation of Serum Amyloid α as an Independent Biomarker for Progression-Free and Overall Survival in Metastatic Renal Cell Cancer Patients
- (2012) Joost S. Vermaat et al. EUROPEAN UROLOGY
- Serum Lactate Dehydrogenase Predicts for Overall Survival Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Inhibition of Mammalian Target of Rapamycin
- (2012) Andrew J. Armstrong et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemokine and Chemokine Receptor Expression in Kidney Tumors: Molecular Profiling of Histological Subtypes and Association With Metastasis
- (2012) Jeffrey C. Gahan et al. JOURNAL OF UROLOGY
- Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
- (2012) Hai T Tran et al. LANCET ONCOLOGY
- Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
- (2012) Wen-Ping Wang et al. World Journal of Surgical Oncology
- Evaluation of a new prognostic score (Munich score) to predict long-term survival after resection of pulmonary renal cell carcinoma metastases
- (2011) Georgios Meimarakis et al. AMERICAN JOURNAL OF SURGERY
- A cytokine and angiogenic factor (CAF) analysis in plasma for selection of sorafenib therapy in patients with metastatic renal cell carcinoma
- (2011) A. J. Zurita et al. ANNALS OF ONCOLOGY
- Circulating endothelial cells are an early predictor in renal cell carcinoma for tumor response to sunitinib
- (2011) Viktor Gruenwald et al. BMC CANCER
- Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors
- (2011) F Farace et al. BRITISH JOURNAL OF CANCER
- Increased mobilisation of circulating endothelial progenitors in von Hippel-Lindau disease and renal cell carcinoma
- (2011) R S Bhatt et al. BRITISH JOURNAL OF CANCER
- Molecular characterization of kidney cancer
- (2011) Andrew Chi et al. CANCER
- Erythrocyte sedimentation rate kinetics as a marker of treatment response and predictor of prognosis in Chinese metastatic renal cell carcinoma patients treated with sorafenib
- (2011) Hai-Liang Zhang et al. INTERNATIONAL JOURNAL OF UROLOGY
- Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
- (2011) Jesus Garcia-Donas et al. LANCET ONCOLOGY
- La neutrophil gelatinase-associated lipocalin, ou LCN 2, facteur d’agressivité dans le carcinome rénal à cellules claires (CRCC)
- (2011) C. Perrin et al. PROGRES EN UROLOGIE
- Dramatic Reduction in Tumor Burden With Neoadjuvant Sunitinib Prior to Bilateral Nephron-sparing Surgery
- (2011) Michael A. Gorin et al. UROLOGY
- Circulating endothelial cells and progenitors: potential biomarkers of renal cell carcinoma
- (2010) Benjamin Namdarian et al. BJU INTERNATIONAL
- Biomarkers Predicting Outcome in Patients with Advanced Renal Cell Carcinoma: Results from Sorafenib Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2010) C. Pena et al. CLINICAL CANCER RESEARCH
- Long-term results of surgical resection for pulmonary metastasis from renal cell carcinoma: a 25-year single-institution experience
- (2010) Ryu Kanzaki et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
- (2010) Börje Ljungberg et al. EUROPEAN UROLOGY
- Contemporary Experience with Laparoscopic Radical Nephrectomy
- (2010) Adam C. Mues et al. Journal of Laparoendoscopic & Advanced Surgical Techniques
- Prospective Clinical Trial of Preoperative Sunitinib in Patients With Renal Cell Carcinoma
- (2010) Nicholas J. Hellenthal et al. JOURNAL OF UROLOGY
- Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib
- (2010) Camillo Porta et al. KIDNEY INTERNATIONAL
- Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the currently used prognostic survival models
- (2009) J. S. Vermaat et al. ANNALS OF ONCOLOGY
- Identification of TNF-α and MMP-9 as potential baseline predictive serum markers of sunitinib activity in patients with renal cell carcinoma using a human cytokine array
- (2009) J L Perez-Gracia et al. BRITISH JOURNAL OF CANCER
- Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial
- (2009) Bernard Escudier et al. JOURNAL OF CLINICAL ONCOLOGY
- Guideline for Management of the Clinical T1 Renal Mass
- (2009) Steven C. Campbell et al. JOURNAL OF UROLOGY
- Quantification of Carbonic Anhydrase IX Expression in Serum and Tissue of Renal Cell Carcinoma Patients Using Enzyme-linked Immunosorbent Assay: Prognostic and Diagnostic Potentials
- (2009) Grace X. Zhou et al. UROLOGY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma
- (2008) Jean-Jacques Patard et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor Activity and Biomarker Analysis of Sunitinib in Patients With Bevacizumab-Refractory Metastatic Renal Cell Carcinoma
- (2008) Brian I. Rini et al. JOURNAL OF CLINICAL ONCOLOGY
- von Hippel-Lindau Gene Status and Response to Vascular Endothelial Growth Factor Targeted Therapy for Metastatic Clear Cell Renal Cell Carcinoma
- (2008) Toni K. Choueiri et al. JOURNAL OF UROLOGY
- Surgical Intervention in Patients with Metastatic Renal Cancer: Metastasectomy and Cytoreductive Nephrectomy
- (2008) Paul Russo et al. UROLOGIC CLINICS OF NORTH AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now